Related Experiment Video
Updated: Jan 10, 2026
Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Small Intestinal Bacterial Overgrowth in Children with Short Bowel Syndrome
Hannah DeGonza1, Thu Anh Pham1, Rasha Elmaoued1
1Division of Gastroenterology, Department of Pediatrics, University of New Mexico, Albuquerque, NM 87131, USA.
Insights
Small Intestinal Bacterial Overgrowth (SIBO) in children with Short Bowel Syndrome (SBS) presents diagnostic and management challenges. Effective care requires a multidisciplinary approach focusing on tailored treatments and improved diagnostic accuracy for better outcomes.
Area of Science:
- Pediatric Gastroenterology
- Microbiology
- Surgical Gastroenterology
Background:
- Short Bowel Syndrome (SBS) in children often leads to Small Intestinal Bacterial Overgrowth (SIBO) due to anatomical and functional changes.
- SIBO in SBS can cause significant gastrointestinal issues, nutritional deficiencies, and severe complications like D-lactic acidosis.
Purpose of the Study:
- To review the characteristics, diagnostic challenges, and management strategies for SIBO in pediatric SBS patients.
- To highlight the need for improved diagnostic tools and integrated care approaches.
Main Methods:
- Literature review of SIBO in pediatric SBS, focusing on pathophysiology, clinical presentation, diagnosis, and treatment.
- Analysis of current diagnostic methods (breath testing, jejunal aspiration) and their limitations in SBS.
- Evaluation of established and emerging therapeutic interventions, including antibiotics and novel agents.
Main Results:
- SIBO is a common complication in pediatric SBS, manifesting with diverse gastrointestinal symptoms and malabsorption.
- Current diagnostic methods for SIBO in SBS patients have significant limitations in accuracy and practicality.
- Antibiotics (e.g., rifaximin) are primary treatments, but recurrence is frequent, necessitating comprehensive management strategies.
Conclusions:
- Managing SIBO in pediatric SBS requires a multidisciplinary team approach, combining gastroenterological, surgical, and nutritional expertise.
- Further research is crucial for developing more accurate diagnostic tools and refining treatment protocols for SIBO in this vulnerable population.
- Emerging therapies like GLP-2 analogs show potential for improving mucosal health and reducing SIBO recurrence in SBS.
Abstract:
Small Intestinal Bacterial Overgrowth (SIBO) is characterized by an abnormal proliferation of bacteria in the small intestine, leading to gastrointestinal symptoms and nutritional deficiencies. Short Bowel Syndrome (SBS), resulting from extensive surgical resection of the small intestine, predisposes children to SIBO due to anatomical disruptions, motility dysfunction, parenteral nutrition dependence, and immune dysregulation. Clinical manifestations of SIBO in SBS include bloating, diarrhea, malabsorption, and failure to thrive, with severe cases leading to complications such as D-lactic acidosis. Diagnosis remains challenging, with breath testing being the most commonly used method despite limitations in accuracy, especially in SBS patients. Jejunal aspiration, the gold standard, presents limitations due to contamination risks, potential for sampling error, and a relatively low diagnostic yield. Management involves antibiotics like rifaximin and metronidazole, alongside strategies to address anatomical dysfunction, optimize nutrition, and prevent recurrence. Adjunctive therapies, including probiotics and dietary modifications, show promise but require further validation in children. Emerging treatments, such as glucagon-like peptide-2 (GLP-2) analogs, may enhance mucosal integrity and reduce SIBO risk. Given the chronic and recurrent nature of SIBO in SBS, a multidisciplinary approach is essential, integrating gastroenterological, surgical, and nutritional care to effectively manage the condition. Future research should focus on improving diagnostic methods, refining treatment protocols, and exploring targeted therapies to enhance outcomes and quality of life for affected children.
Related Concept Videos
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:23Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:23Renewal of Intestinal Stem Cells